SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: Hyperalgesia - Pipeline Review, H2 2013 Research Report

[February 07, 2014]

Research and Markets: Hyperalgesia - Pipeline Review, H2 2013 Research Report

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/jwrj75/hyperalgesia) has announced the addition of the "Hyperalgesia - Pipeline Review, H2 2013" report to their offering.

'Hyperalgesia - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Hyperalgesia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hyperalgesia.

Scope

- A snapshot of the global therapeutic scenario for Hyperalgesia.

- A review of the Hyperalgesia products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of deveopment ranging from discovery till registration stages.


- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Hyperalgesia pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Key Topics Covered:

Introduction

Hyperalgesia Overview

Therapeutics Development

Pipeline Products for Hyperalgesia - Overview

Pipeline Products for Hyperalgesia - Comparative Analysis

Hyperalgesia - Therapeutics under Development by Companies

Hyperalgesia - Therapeutics under Investigation by Universities/Institutes

Hyperalgesia - Pipeline Products Glance

Early Stage Products

Hyperalgesia - Products under Development by Companies

Hyperalgesia - Products under Investigation by Universities/Institutes

Hyperalgesia - Companies Involved in Therapeutics Development

Shionogi & Co., Ltd.

Hyperalgesia - Therapeutics Assessment

Drug Profiles

LASSBio-873 - Drug Profile

Drug For Neuropathic Pain - Drug Profile

Drug For Methylglyoxal Induced Pains - Drug Profile

P2X3 Receptor Antagonist - Drug Profile

Protein Kinase 1 Alpha Inhibitor - Drug Profile

Selective Phospholipase A2 Inhibitors - Drug Profile

Hyperalgesia - Dormant Projects

Companies Mentioned

Shionogi & Co., Ltd.

For more information visit http://www.researchandmarkets.com/research/jwrj75/hyperalgesia

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved.